• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分化型甲状腺癌管理与随访中的争议:超越指南

Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines.

作者信息

Ahmadieh Hala, Azar Sami T

机构信息

Division of Endocrinology, Department of Internal Medicine, American University of Beirut Medical Center, 3 Dag Hammarskjold Plaza, New York, NY 10017, USA.

出版信息

J Thyroid Res. 2012;2012:512401. doi: 10.1155/2012/512401. Epub 2012 Dec 30.

DOI:10.1155/2012/512401
PMID:23326756
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3544283/
Abstract

Thyroid cancer is among the most common endocrine malignancies. Genetic and environmental factors play an important role in the pathogenesis of differentiated thyroid cancer. Both have good prognosis but with frequent recurrences. Cancer staging is an essential prognostic part of cancer management. There are multiple controversies in the management and followup of differentiated thyroid cancer. Debate still exists with regard to the optimal surgical approach but trends toward a more conservative approach, such as lobectomy, are being more favored, especially in papillary thyroid cancer, of tumor sizes less than 4 cm, in the absence of other high-risk suggestive features. Survival of patients with well-differentiated thyroid cancer was adversely affected by lymph node metastases. Prophylactic central LN dissection did improve accuracy in staging and decrease postop TG level, but it had no effect on small-sized tumors. Conservative approach was more applied with regard to the need and dose of radioiodine given postoperatively. There have been several advancements in the management of radioiodine resistant advanced differentiated thyroid cancers. Appropriate followup is required based on risk stratification of patients postoperatively. Many studies are still ongoing in order to reach the optimal management and followup of differentiated thyroid cancer.

摘要

甲状腺癌是最常见的内分泌恶性肿瘤之一。遗传和环境因素在分化型甲状腺癌的发病机制中起着重要作用。两者预后均良好,但复发频繁。癌症分期是癌症管理中至关重要的预后部分。在分化型甲状腺癌的管理和随访方面存在诸多争议。关于最佳手术方式仍存在争论,但更保守的方法,如甲状腺叶切除术,正越来越受到青睐,尤其是对于肿瘤大小小于4厘米、且无其他高风险提示特征的乳头状甲状腺癌。分化型甲状腺癌患者的生存会受到淋巴结转移的不利影响。预防性中央淋巴结清扫确实提高了分期的准确性并降低了术后甲状腺球蛋白水平,但对小肿瘤无效。在术后放射性碘的使用需求和剂量方面,更倾向于采用保守方法。在放射性碘难治性晚期分化型甲状腺癌的管理方面已经取得了一些进展。术后需要根据患者的风险分层进行适当的随访。为了实现分化型甲状腺癌的最佳管理和随访,许多研究仍在进行中。

相似文献

1
Controversies in the management and followup of differentiated thyroid cancer: beyond the guidelines.分化型甲状腺癌管理与随访中的争议:超越指南
J Thyroid Res. 2012;2012:512401. doi: 10.1155/2012/512401. Epub 2012 Dec 30.
2
Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.直径小于2厘米的乳头状甲状腺癌预防性淋巴结清扫:对放射性碘治疗的影响
J Clin Endocrinol Metab. 2009 Apr;94(4):1162-7. doi: 10.1210/jc.2008-1931. Epub 2008 Dec 30.
3
Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.甲状腺癌的管理:英国国家多学科指南
J Laryngol Otol. 2016 May;130(S2):S150-S160. doi: 10.1017/S0022215116000578.
4
Risk of recurrence in a homogeneously managed pT3-differentiated thyroid carcinoma population.同质管理的pT3分化型甲状腺癌人群中的复发风险。
Langenbecks Arch Surg. 2018 May;403(3):325-332. doi: 10.1007/s00423-018-1657-2. Epub 2018 Feb 14.
5
Robot-assisted Sistrunk's operation, total thyroidectomy, and neck dissection via a transaxillary and retroauricular (TARA) approach in papillary carcinoma arising in thyroglossal duct cyst and thyroid gland.经腋后(TARA)入路机器人辅助施行 Sistrunk 手术、甲状腺全切除术和颈淋巴结清扫术治疗甲状舌管囊肿和甲状腺起源的乳头状癌
Ann Surg Oncol. 2012 Dec;19(13):4259-61. doi: 10.1245/s10434-012-2674-y. Epub 2012 Oct 16.
6
Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.VI 级淋巴结清扫术不会降低分化型甲状腺癌患者接受碘-131 消融治疗后的碘摄取。
World J Surg. 2012 Jun;36(6):1255-61. doi: 10.1007/s00268-012-1507-2.
7
Location and Causation of Residual Lymph Node Metastasis After Surgical Treatment of Regionally Advanced Differentiated Thyroid Cancer.局部晚期分化型甲状腺癌术后残留淋巴结转移的部位和原因。
Thyroid. 2018 May;28(5):593-600. doi: 10.1089/thy.2017.0434. Epub 2018 Apr 23.
8
Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer.分化型甲状腺癌预防性中央区淋巴结清扫术
Acta Clin Croat. 2020 Jun;59(Suppl 1):87-95. doi: 10.20471/acc.2020.59.s1.11.
9
The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.手术、放射性碘及外照射放疗对分化型甲状腺癌患者临床结局的影响。
Cancer. 1998 Jan 15;82(2):375-88.
10
Sternal metastasis as first manifestation of a papillary thyroid carcinoma: A case report.胸骨转移作为甲状腺乳头状癌的首发表现:一例报告
Int J Surg Case Rep. 2021 Mar;80:105663. doi: 10.1016/j.ijscr.2021.105663. Epub 2021 Feb 18.

引用本文的文献

1
The necessity of thyroid-stimulating hormone suppression therapy for low-risk differentiated thyroid carcinoma following hemithyroidectomy: A systematic review and meta-analysis.甲状腺叶切除术后低危分化型甲状腺癌促甲状腺激素抑制治疗的必要性:一项系统评价和荟萃分析。
Heliyon. 2024 Nov 22;10(23):e40574. doi: 10.1016/j.heliyon.2024.e40574. eCollection 2024 Dec 15.
2
Upregulation of miR-142 in papillary thyroid carcinoma tissues: a report based on in silico and in vitro analysis.甲状腺乳头状癌组织中miR-142的上调:基于计算机模拟和体外分析的报告
Mol Biol Res Commun. 2022;11(3):133-141. doi: 10.22099/mbrc.2022.43947.1757.
3
Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.分化型甲状腺癌:流行地区行甲状腺叶加峡部切除术的可行性
G Chir. 2015 Nov-Dec;36(6):257-62. doi: 10.11138/gchir/2015.36.6.257.
4
Clinical impact of microscopic extrathyroidal extension in patients with papillary thyroid microcarcinoma treated with hemithyroidectomy.甲状腺半切术治疗的甲状腺微小乳头状癌患者中显微镜下甲状腺外侵犯的临床影响
J Endocrinol Invest. 2014 Feb;37(2):167-73. doi: 10.1007/s40618-013-0025-x. Epub 2014 Jan 9.

本文引用的文献

1
Sociodemographic Predictors of Survival in Differentiated Thyroid Cancer: Results from the SEER Database.分化型甲状腺癌生存的社会人口学预测因素:来自监测、流行病学和最终结果(SEER)数据库的结果
ISRN Endocrinol. 2012;2012:384707. doi: 10.5402/2012/384707. Epub 2012 Aug 16.
2
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.甲状腺癌的低剂量碘 131 消融联合促甲状腺激素治疗。
N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.
3
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.低危甲状腺癌患者的碘 131 消融策略。
N Engl J Med. 2012 May 3;366(18):1663-73. doi: 10.1056/NEJMoa1108586.
4
Differentiated thyroid cancer: management of patients with radioiodine nonresponsive disease.分化型甲状腺癌:放射性碘难治性疾病患者的管理
J Thyroid Res. 2012;2012:618985. doi: 10.1155/2012/618985. Epub 2012 Feb 28.
5
TSH-suppressive treatment in differentiated thyroid cancer. A dogma under review.分化型甲状腺癌的促甲状腺激素抑制治疗:一项正在重新审视的教条。
Endocrinol Nutr. 2012 Feb;59(2):125-30. doi: 10.1016/j.endonu.2011.10.002. Epub 2011 Dec 14.
6
Initial therapy with either thyroid lobectomy or total thyroidectomy without radioactive iodine remnant ablation is associated with very low rates of structural disease recurrence in properly selected patients with differentiated thyroid cancer.对于经过恰当选择的分化型甲状腺癌患者,初始治疗采用甲状腺叶切除术或全甲状腺切除术且不进行放射性碘残留消融,其结构疾病复发率非常低。
Clin Endocrinol (Oxf). 2011 Jul;75(1):112-9. doi: 10.1111/j.1365-2265.2011.04002.x.
7
Surgery for papillary thyroid carcinoma: is lobectomy enough?甲状腺乳头状癌手术:肺叶切除术足够了吗?
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1055-61. doi: 10.1001/archoto.2010.181.
8
Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma.唑来膦酸治疗分化型甲状腺癌骨转移。
Thyroid. 2011 Jan;21(1):31-5. doi: 10.1089/thy.2010.0169. Epub 2010 Nov 8.
9
Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.基于日本甲状腺外科学会和日本内分泌外科学会管理的新制定指南的分化型甲状腺癌治疗策略。
World J Surg. 2011 Jan;35(1):111-21. doi: 10.1007/s00268-010-0832-6.
10
Molecular testing for somatic mutations improves the accuracy of thyroid fine-needle aspiration biopsy.体细胞突变的分子检测提高了甲状腺细针穿刺活检的准确性。
World J Surg. 2010 Nov;34(11):2589-94. doi: 10.1007/s00268-010-0720-0.